One child dies from malaria every minute in Africa, 83% of which are under the age of five.
Last week, the world’s first malaria vaccine, developed by GlaxoSmithKline, won a green light from European drugs regulators for the prevention of malaria in young children in sub-Saharan Africa. The World Health Organisation (WHO) will now assess how the vaccine might be used alongside other tools to prevent malaria.
In today’s video showcase, GlaxoSmithKline detail their 30-year quest to develop a malaria vaccine.
Do you have a video you would like the sector to see? Contact us.